Internal Medicine, Endocrinology, Diabetes, & Metabolism · Southgate, MI
NPI
1578543849
Since 2006
Specialty
Internal Medicine, Endocrinology, Diabetes, & Metabolism
Code 207RE0101X
Group practices
1
Medicare group memberships
Hospitals
5
Hospital affiliations
15125 Northline Rd
Southgate, MI, 48195
Phone (734) 282-3138
Groups this clinician bills Medicare through
Medicare paid, 2024
$151K
1,945 services
Medicare patients, 2024
799
Average age 73
Drug cost, 2024
$2.6M
6,436 prescriptions
Company payments, 2025
$6,357
From 36 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Sleman A Khoury was code 99214 (office e&m - established), 717 times for 486 patients. In total Sleman A Khoury billed 1,945 services in 18 codes, and Medicare paid $151K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2020-12-20.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 717 | 486 | $90.12 | $65K |
| 99232 Hospital E&M - Subsequent | Facility | 304 | 108 | $63.17 | $19K |
| 99231 Hospital E&M - Subsequent | Facility | 274 | 106 | $39.07 | $11K |
| 95251 Test - Miscellaneous | Office | 151 | 101 | $25.25 | $3,813 |
| 99222 Hospital E&M - Initial | Facility | 117 | 113 | $103.26 | $12K |
| 99223 Hospital E&M - Initial | Facility | 68 | 63 | $138.66 | $9,429 |
| 99215 Office E&M - Established | Office | 66 | 62 | $134.16 | $8,854 |
| 99213 Office E&M - Established | Office | 57 | 55 | $61.98 | $3,533 |
| 76536 Ultrasound - Nonspecific | Office | 57 | 56 | $77.97 | $4,445 |
| 99205 Office E&M - New | Office | 48 | 48 | $158.27 | $7,597 |
| 99233 Hospital E&M - Subsequent | Facility | 33 | 23 | $96.03 | $3,169 |
| 10005 Other Organ Systems | Office | 16 | 16 | $108.20 | $1,731 |
| 76942 Ultrasound - Nonspecific | Office | 13 | 13 | $46.23 | $601 |
By year: 2022 $157K for 1,918 services; 2023 $160K for 2,042 services; 2024 $151K for 1,945 services.
Medicare prescription drug claims, 2024
In 2024, the drug Sleman A Khoury prescribed most often to Medicare patients was Levothyroxine Sodium, with 1,279 prescriptions and refills. In total Sleman A Khoury wrote 6,436 Medicare prescriptions that cost $2.6M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Levothyroxine Sodium Generic | 1,279 | 3,605 | 536 | $16K |
| Jardiance Empagliflozin | 277 | 685 | 91 | $385K |
| Metformin Hcl Generic | 276 | 749 | 106 | $2,897 |
| Ozempic Semaglutide | 261 | 573 | 101 | $538K |
| Lantus Solostar Insulin Glargine,hum.Rec.Anlog | 247 | 671 | 123 | $70K |
| Atorvastatin Calcium Generic | 191 | 545 | 75 | $2,235 |
| Nano 2nd Gen Pen Needle Pen Needle, Diabetic | 161 | 418 | 84 | $20K |
| Glimepiride Generic | 154 | 420 | 61 | $1,766 |
| Humalog Kwikpen U-100 Insulin Lispro | 134 | 389 | 73 | $68K |
| Lisinopril Generic | 132 | 374 | 52 | $897 |
| Rosuvastatin Calcium Generic | 123 | 344 | 53 | $1,868 |
| Novolog Flexpen Insulin Aspart | 123 | 303 | 59 | $54K |
| Metformin Hcl Er Metformin Hcl | 120 | 361 | 53 | $1,311 |
| Trulicity Dulaglutide | 117 | 250 | 50 | $240K |
| Methimazole Generic | 113 | 299 | 49 | $1,937 |
Brand drugs: 2,502 claims; generic drugs: 3,482 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Sleman A Khoury $6,357 ($6,357 in general payments such as food, travel and fees) from 36 companies. The largest payer was Ascendis Pharma Endocrinology Inc with $2,346.
| Company | Payments | Amount |
|---|---|---|
| Ascendis Pharma Endocrinology Inc ASND | 9 | $2,346 |
| Novo Nordisk Inc NVO | 24 | $363 |
| Tandem Diabetes Care, Inc. TNDM | 11 | $338 |
| Neurocrine BioSciences, Inc. NBIX | 7 | $286 |
| Amgen Inc. AMGN | 16 | $280 |
| Lilly USA, LLC LLY | 19 | $266 |
| Abbott Laboratories ABT | 12 | $223 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 10 | $185 |
| Dexcom, Inc. DXCM | 8 | $180 |
| Bayer Healthcare Pharmaceuticals Inc. BAYN.DE | 8 | $171 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.